Evolus Correlations
EOLS Stock | USD 6.14 0.15 2.50% |
The correlation of Evolus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Evolus Correlation With Market
Modest diversification
The correlation between Evolus Inc and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Evolus Stock
0.76 | VCEL | Vericel Corp Ord | PairCorr |
0.67 | DRMA | Dermata Therapeutics | PairCorr |
0.73 | VRAX | Virax Biolabs Group | PairCorr |
0.68 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.92 | VRTX | Vertex Pharmaceuticals | PairCorr |
Moving against Evolus Stock
0.84 | DRUG | Bright Minds Biosciences | PairCorr |
0.81 | VALN | Valneva SE ADR Upward Rally | PairCorr |
0.77 | VCYT | Veracyte | PairCorr |
0.77 | DSGN | Design Therapeutics Trending | PairCorr |
0.75 | KG | KING PHARMACEUTICALS INC Symbol Change | PairCorr |
0.75 | DMAC | DiaMedica Therapeutics | PairCorr |
0.72 | DRTS | Alpha Tau Medical | PairCorr |
0.66 | EQ | Equillium | PairCorr |
0.64 | VRDN | Viridian Therapeutics | PairCorr |
0.6 | DNTH | Dianthus Therapeutics | PairCorr |
0.6 | DRRX | Durect | PairCorr |
0.51 | VIVS | VivoSim Labs, Symbol Change | PairCorr |
0.48 | CDIOW | Cardio Diagnostics | PairCorr |
0.43 | VRNA | Verona Pharma PLC | PairCorr |
0.35 | A | Agilent Technologies | PairCorr |
0.32 | DWTX | Dogwood Therapeutics, Symbol Change | PairCorr |
0.83 | ELAN | Elanco Animal Health | PairCorr |
0.81 | ESPR | Esperion Therapeutics | PairCorr |
0.8 | ETON | Eton Pharmaceuticals | PairCorr |
0.74 | VSTM | Verastem | PairCorr |
0.68 | ENTO | Entero Therapeutics, | PairCorr |
0.64 | VTGN | VistaGen Therapeutics | PairCorr |
0.64 | VYGR | Voyager Therapeutics | PairCorr |
0.64 | ENGN | enGene Holdings Common | PairCorr |
0.58 | ELTX | Elicio Therapeutics | PairCorr |
Related Correlations Analysis
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | EGRX | ||
0.0 | 0.88 | 0.69 | -0.22 | 0.27 | -0.53 | COLL | ||
0.0 | 0.88 | 0.42 | -0.27 | 0.51 | -0.82 | ANIP | ||
0.0 | 0.69 | 0.42 | -0.1 | -0.05 | -0.08 | INCR | ||
0.0 | -0.22 | -0.27 | -0.1 | -0.19 | 0.3 | SLDB | ||
0.0 | 0.27 | 0.51 | -0.05 | -0.19 | -0.62 | CRNX | ||
0.0 | -0.53 | -0.82 | -0.08 | 0.3 | -0.62 | SYRS | ||
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Evolus Stock performing well and Evolus Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Evolus' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EGRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
COLL | 1.86 | 0.20 | 0.09 | 0.32 | 1.98 | 3.58 | 17.15 | |||
ANIP | 1.59 | 0.45 | 0.32 | 0.48 | 1.06 | 4.08 | 20.88 | |||
INCR | 2.08 | 0.17 | 0.04 | 4.89 | 1.97 | 5.13 | 17.87 | |||
SLDB | 3.34 | 0.37 | 0.12 | 0.33 | 3.05 | 8.51 | 22.20 | |||
CRNX | 3.07 | 0.44 | 0.18 | 0.31 | 2.56 | 6.35 | 33.15 | |||
SYRS | 8.32 | (0.96) | 0.00 | (0.33) | 0.00 | 19.05 | 92.70 |
Evolus Corporate Management
Tatjana Mitchell | Chief Officer | Profile | |
Jessica Novak | Senior Resources | Profile | |
Tomoko YamagishiDressler | Chief Officer | Profile | |
CCFP DipSportMed | Chief RD | Profile | |
David Erickson | VP Relations | Profile |